BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23213189)

  • 1. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
    Haiman CA; Stram DO; Vickers AJ; Wilkens LR; Braun K; Valtonen-André C; Peltola M; Pettersson K; Waters KM; Marchand LL; Kolonel LN; Henderson BE; Lilja H
    J Natl Cancer Inst; 2013 Feb; 105(3):237-43. PubMed ID: 23213189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
    Waters KM; Stram DO; Le Marchand L; Klein RJ; Valtonen-André C; Peltola MT; Kolonel LN; Henderson BE; Lilja H; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2639-46. PubMed ID: 20736317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
    Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
    Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
    Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort.
    Park SY; Wilkens LR; Morris JS; Henderson BE; Kolonel LN
    Prostate; 2013 Feb; 73(3):261-6. PubMed ID: 22851289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
    Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
    Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
    Lonergan PE; Vertosick EA; Assel M; Sjoberg DD; Haese A; Graefen M; Boorjian SA; Klee GG; Cooperberg MR; Pettersson K; Routila E; Vickers AJ; Lilja H
    BJU Int; 2021 Aug; 128(2):218-224. PubMed ID: 33306251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.
    Assel M; Sjöblom L; Murtola TJ; Talala K; Kujala P; Stenman UH; Taari K; Auvinen A; Vickers A; Visakorpi T; Tammela TL; Lilja H
    Eur Urol Focus; 2019 Jul; 5(4):561-567. PubMed ID: 29137895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of diabetes with prostate cancer risk in the multiethnic cohort.
    Waters KM; Henderson BE; Stram DO; Wan P; Kolonel LN; Haiman CA
    Am J Epidemiol; 2009 Apr; 169(8):937-45. PubMed ID: 19240222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Anthropometric Measures With the Risk of Prostate Cancer in the Multiethnic Cohort.
    Sattayapiwat O; Wan P; Hernandez BY; Le Marchand L; Wilkens L; Haiman CA
    Am J Epidemiol; 2021 Sep; 190(9):1770-1783. PubMed ID: 33751036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.
    Park SY; Cooney RV; Wilkens LR; Murphy SP; Henderson BE; Kolonel LN
    Eur J Cancer; 2010 Mar; 46(5):932-6. PubMed ID: 20064705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen testing among young men: an opportunity to improve value.
    Lange SM; Ambrose JP; Flynn MC; Lowrance WT; Hanson HA; O'Neil BB
    Cancer Med; 2021 Mar; 10(6):2075-2079. PubMed ID: 33626214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii.
    Oshiro CES; Frankland TB; Mor J; Wong CP; Martinez YT; Aruga CKK; Honda S
    JAMA Netw Open; 2022 Jan; 5(1):e2144381. PubMed ID: 35050353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort.
    Maskarinec G; Grandinetti A; Matsuura G; Sharma S; Mau M; Henderson BE; Kolonel LN
    Ethn Dis; 2009; 19(1):49-55. PubMed ID: 19341163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
    Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
    Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States).
    Stram DO; Hankin JH; Wilkens LR; Park S; Henderson BE; Nomura AM; Pike MC; Kolonel LN
    Cancer Causes Control; 2006 Nov; 17(9):1193-207. PubMed ID: 17006725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
    Hoogland AM; Dahlman A; Vissers KJ; Wolters T; Schröder FH; Roobol MJ; Bjartell AS; van Leenders GJ
    BJU Int; 2011 Oct; 108(8):1356-62. PubMed ID: 21410630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dietary Inflammatory Index and All-Cause, Cardiovascular Disease, and Cancer Mortality in the Multiethnic Cohort Study.
    Park SY; Kang M; Wilkens LR; Shvetsov YB; Harmon BE; Shivappa N; Wirth MD; Hébert JR; Haiman CA; Le Marchand L; Boushey CJ
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.